Connect with us

Life Sciences

Google’s New LLM- MedLM

What is MedLM? Google has introduced MedLM, a set of healthcare-specific foundation models, and is now offering it to some US-based Google Cloud clients…

Published

on

This article was originally published by AITHORITY

What is MedLM?

Google has introduced MedLM, a set of healthcare-specific foundation models, and is now offering it to some US-based Google Cloud clients through the Vertex AI platform. At the moment, two models are constructed using Med-PaLM 2 under MedLM.

New to the Google ecosystem is MedLM, a collection of artificial intelligence models developed specifically for use in healthcare. The Vertex AI platform will make MedLM, which is based on Google’s medical domain large language model (LLM) Med-PaLM 2, available to Google Cloud customers in the US. Google states that MedLM was developed via extensive testing and partnerships with global healthcare organizations.

Read: Top 10 Benefits Of AI In The Real Estate Industry

To Address Particular Intricacies in the Medical Area

Google said that these models are good at summarizing medical talks and quickly analyzing large pharmaceutical databases. Practical insights from real-world events, such as resolving medical inquiries from healthcare practitioners, formed the basis of the MedLM models. As for the MedLM package, Google intends to incorporate Gemini-based models as well. To better address the intricacies of the healthcare industry, this expansion seeks to expand functions and provide a more varied range of solutions.

Two types of AI will be available: one with more processing power and more features for complicated and multi-faceted activities, and another with more generalizability and flexibility for use in different healthcare processes, making it easier to tailor to individual needs.

Collaborations

To improve patient access, experience, and outcomes, Google is partnering with Accenture to use generative AI. Healthcare firms may improve patient outcomes by combining MedLM with Google Cloud’s Claims Acceleration Suite. Deloitte and Google Cloud are collaborating on a pilot program called MedLM to help contact center agents find the best providers for their clients by making it easier to get information from provider directories and benefits paperwork.

Read 10 AI In Manufacturing Trends To Look Out For In 2024

MedLM: The Next Generation of MedGen AI

Enabling professionals with the safe and responsible use of generative AI is our top priority as they bring this technology’s transformational promise to healthcare. For this reason, Google maintains tight relationships with healthcare leaders, academics, organizations in the field of health and life sciences, and those providing healthcare daily. From developing the first LLM to achieve a passing score (>60%) on U.S. medical-licensing-exam-style questions (published in Nature) to improving it to an expert-level score (86.5%), and finally applying it in real-world scenarios through a measured approach, we are excited by the progress we’ve seen in just one year. As they look back on 2023 and wrap out the year by making MedLM available to additional healthcare institutions, they are filled with anticipation for what the future holds and their unwavering commitment to advancing groundbreaking research in the health and life sciences.

Read: 4 Common Myths Related To Women In The Workplace

[To share your insights with us, please write to sghosh@martechseries.com]

The post Google’s New LLM- MedLM appeared first on AiThority.



life sciences

artificial intelligence

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending